Cargando…
A Bi-Functional Targeted P28-NRC Chimeric Protein with Enhanced Cytotoxic Effects on Breast Cancer Cell Lines
One of the emerging therapeutic strategies for targeted therapy of cancer is the use of chimeric proteins. The p28 peptide has the ability of selective entrance and activating apoptosis in breast cancer cells. The NRC antimicrobial peptide showed cytotoxic activity on various breast cancer cell line...
Autores principales: | Soleimani, Meysam, Mirmohammmad Sadeghi, Hamid, Jahanian-Najafabadi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706745/ https://www.ncbi.nlm.nih.gov/pubmed/31531057 http://dx.doi.org/10.22037/ijpr.2019.2392 |
Ejemplares similares
-
Expression and purification of toxic anti-breast cancer p28-NRC chimeric protein
por: Soleimani, Meysam, et al.
Publicado: (2016) -
Theoretical design of a new chimeric protein for the treatment of breast cancer
por: Soleimani, Meysam, et al.
Publicado: (2016) -
In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells
por: Ghavimi, Reza, et al.
Publicado: (2020) -
NRC: not enough data.
por: Greene, L A
Publicado: (2000) -
Comparaison de la jauge NRC 524
por: Dubler, H
Publicado: (1969)